Table 3.
Clinical and biological characteristics for colorectal cancer patients who underwent an operation.
| Factor | T2-CTC positive(≥4 CTCs), (n = 29) | T2-CTC negative(1–3 CTCs), (n = 11) | p-value1 |
|---|---|---|---|
| Age, years | 64.83 (9.77) | 63.18 (11.32) | 0.612 |
| Preoperative lymphocyte count | 1.71 (0.98) | 1.82 (0.62) | 0.39 |
| Preoperative platelets | 292.97 (91.28) | 359.45 (152.01) | 0.12 |
| Preoperative neutrophils | 4.48 (1.66) | 5.70 (2.09) | 0.23 |
| Lymph node harvest | 28.86 (19.34) | 39.45 (17.87) | 0.06 |
| Positive lymph node harvest | 1.31 (2.19) | 3.27 (3.77) | 0.09 |
| Preoperative CEA | 19.59 (74.56) | 92.61 (202.87) | 0.18 |
| Preoperative CA19.9 | 253.61 (1269) | 101.03 (206, 36) | 0.53 |
| Preoperative albumin | 4.37 (0.7) | 4.70 (0.29) | 0.16 |
1Mann–Whitney test.
CEA, carcinoembryonic antigen; CA19.9, carbohydrate antigen 19-9; CTCs, circulating tumor cells.